Amgen (AMGN) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $79.2 billion.
- Amgen's Total Non-Current Liabilities fell 523.24% to $79.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $79.2 billion, marking a year-over-year decrease of 523.24%. This contributed to the annual value of $79.2 billion for FY2025, which is 523.24% down from last year.
- Amgen's Total Non-Current Liabilities amounted to $79.2 billion in Q4 2025, which was down 523.24% from $77.9 billion recorded in Q3 2025.
- In the past 5 years, Amgen's Total Non-Current Liabilities registered a high of $86.2 billion during Q4 2023, and its lowest value of $45.1 billion during Q2 2021.
- For the 5-year period, Amgen's Total Non-Current Liabilities averaged around $68.5 billion, with its median value being $77.9 billion (2025).
- Its Total Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 5482.47% in 2023, then plummeted by 564.16% in 2025.
- Over the past 5 years, Amgen's Total Non-Current Liabilities (Quarter) stood at $47.9 billion in 2021, then increased by 16.36% to $55.7 billion in 2022, then soared by 54.82% to $86.2 billion in 2023, then fell by 3.05% to $83.6 billion in 2024, then dropped by 5.23% to $79.2 billion in 2025.
- Its Total Non-Current Liabilities stands at $79.2 billion for Q4 2025, versus $77.9 billion for Q3 2025 and $78.0 billion for Q2 2025.